
Anna Benefiel has spent over 20 years in healthcare innovation, and she's tired of watching life sciences sit on the sidelines of quantum computing. In this episode, she makes a direct case for why pharma needs to stop treating quantum as a future problem and start treating it as a present opportunity. We get into what quantum actually does that classical computing cannot, why probabilistic nuance matters for complex biological problems, and where the real near-term value lives: clinical trial optimization, supply chain, and cell culture yields.We also dig into what happens when you stack quantum on top of AI. Anna points to models already using standard histopathology slides to generate spatial proteomic maps for lung cancer, and argues quantum is what takes discoveries like that to the next order of magnitude. *The views represented on this podcast are not a reflection of Strangeworks.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Episode 18: Why Does mRNA Keep Breaking AI Models?

Episode 17: Garbage Data, Toxic Exposure, and the AI Gap in Environmental Health

Episode 16: Why Chemistry has Held Drug Discovery Back

Episode 14: The Drug Discovery Problems AI Alone Can't Solve
Free AI-powered recaps of From Models to Medicine and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.